Page last updated: 2024-08-24

isothiocyanic acid and Retinal Neovascularization

isothiocyanic acid has been researched along with Retinal Neovascularization in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chikaraishi, Y; Hara, H; Shimazawa, M; Yokota, K; Yoshino, K	1

Other Studies

1 other study(ies) available for isothiocyanic acid and Retinal Neovascularization

Article	Year
CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo. Current neurovascular research, 2009, Volume: 6, Issue:3 Topics: ADAM Proteins; ADAM17 Protein; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Ischemia; Isothiocyanates; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Sulfones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A	2009

Article

Year

CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.

Current neurovascular research, 2009, Volume: 6, Issue:3

Topics: ADAM Proteins; ADAM17 Protein; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Ischemia; Isothiocyanates; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Sulfones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2009